Klinikum Darmstadt GmbH

Darmstadt, Hesse 64283

0 studies enrolling now · 2 studies all time

What they study most

Autologous Stem Cell Transplant, Melanoma, Multiple Myeloma

Studies at this site

• A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery — Running, not enrolling
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant — Completed